Ibrexafungerp citrate

Overview

Ibrexafungerp citrate (MK 3118 citrate) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp citrate is an investigational agent for the treatment of Candida and Aspergillus infections.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Fungal Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Fungal

Product Information

• Catalog No.: HY-107126A
• CAS No.: 1965291-08-0
• Molecular Formula: C50H75N5O11
• Molecular Weight: 922.16
• Purity: 99.38%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (2.71 mM); Clear solution
• Availability: In-stock

Source

Original product source